BRIEF published on 06/18/2024 at 07:05, 2 years 2 months ago EUROAPI et Priothera s'associent au CDMO pour faire progresser le projet d'oncologie CDMO Oncologie EUROAPI Priothera Mocravimod
BRIEF published on 06/18/2024 at 07:05, 2 years 2 months ago EUROAPI and Priothera Enter CDMO Collaboration to Advance Oncology Project CDMO Oncology EUROAPI Priothera Mocravimod
PRESS RELEASE published on 06/18/2024 at 07:00, 2 years 2 months ago EUROAPI and Priothera enter into CDMO collaboration to advance oncology project EUROAPI and Priothera have entered a 5-year CDMO collaboration to advance an innovative oncology molecule for blood cancers, aiming to improve CAR-T cell therapies EUROAPI Priothera Mocravimod CDMO Collaboration Oncology Project
BRIEF published on 06/06/2024 at 17:58, 2 years 3 months ago EUROAPI accélère les discussions de financement pour le projet FOCUS-27 Financement Transformation Stratégique EUROAPI FOCUS-27
BRIEF published on 06/06/2024 at 17:58, 2 years 3 months ago EUROAPI Accelerates Financing Discussions for FOCUS-27 Project Financing Strategic Transformation EUROAPI FOCUS-27
PRESS RELEASE published on 06/06/2024 at 17:53, 2 years 3 months ago Information marché Financement du projet de transformation FOCUS-27 EUROAPI a mandaté un tiers pour le financement de son projet stratégique FOCUS-27. Des progrès importants ont été réalisés. Découvrez les détails de cette démarche Financement EUROAPI FOCUS-27 Mandataire Ad Hoc Projet De Transformation
PRESS RELEASE published on 06/06/2024 at 17:53, 2 years 3 months ago Market update : FOCUS-27 transformation project financing EUROAPI appoints mandataire ad hoc for FOCUS-27 project financing discussions, making substantial progress. Learn more about EUROAPI and its active ingredient solutions Project Financing EUROAPI FOCUS-27 Mandataire Ad Hoc Active Ingredient Solutions
BRIEF published on 06/06/2024 at 07:05, 2 years 3 months ago EUROAPI Reaches Major Health IPCEI Milestone with Official Notification from European Commission Pharmaceutical Industry European Commission EUROAPI IPCEI Public Funding
BRIEF published on 06/06/2024 at 07:05, 2 years 3 months ago EUROAPI franchit une étape majeure de l'IPCEI en matière de santé avec une notification officielle de la Commission européenne Industrie Pharmaceutique EUROAPI Commission Européenne IPCEI Financement Publique
PRESS RELEASE published on 06/06/2024 at 07:00, 2 years 3 months ago EUROAPI reaches major Health IPCEI milestone with official notification from European Commission EUROAPI selected for EUR 1 billion IPCEI funding by European Commission to enhance pharmaceutical sector competitiveness and sustainability European Commission R&D EUROAPI IPCEI Pharmaceutical Sector
Published on 09/12/2026 at 02:35, 11 hours 1 minute ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 36 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 31 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 11 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 36 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 5 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 21 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 25 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 51 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 20 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
